MedTrace Logo

SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)

NCT04527419 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 545

Last updated 2025-08-26

No results posted yet for this study

Summary

This is a study from Eastern Cooperative Thoracic Oncology Project, numbered as ECTOP-1009. Systematically mediastinal lymph node dissection or not in clinical stage T1 ground-glass dominated invasive lung adenocarcinoma: a multi-center, prospective clinical trial

Conditions

  • Carcinoma, Non-Small-Cell Lung

Interventions

PROCEDURE

No mediastinal lymph node dissection

No mediastinal lymph node dissection will be performed.

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Haiquan Chen, Ph.D · Shanghai Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-09
Primary Completion
2026-07-21
Completion
2027-02-09

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04527419 on ClinicalTrials.gov